Virogenics, Inc.
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Safety, Tolerability and Pharmacokinetics of CMS121, a Drug Candidate for Alzheimer's Disease, in Healthy Subjects (NCT05318040) | Virogenics, Inc. | 2022-05-01 |
Track Virogenics, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.